Viewing Study NCT06463457


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-01-23 @ 3:12 PM
Study NCT ID: NCT06463457
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-27
First Post: 2024-06-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
Sponsor: Atish Choudhury, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Advanced Prostate Cancer View
None Hormone Sensitive Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone-Sensitive Prostate Cancer View
None Prostate Cancer View
None Advanced Prostate Cancer View